RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes
Recommended Citation
Mall R, Cerulo L, Garofano L, Frattini V, Kunji K, Bensmail H, Sabedot TS, Noushmehr H, Lasorella A, Iavarone A, and Ceccarelli M. RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes. Nucleic Acids Res 2018; 46(7):e39.
Document Type
Article
Publication Date
4-20-2018
Publication Title
Nucleic acids research
Abstract
We propose a generic framework for gene regulatory network (GRN) inference approached as a feature selection problem. GRNs obtained using Machine Learning techniques are often dense, whereas real GRNs are rather sparse. We use a Tikonov regularization inspired optimal L-curve criterion that utilizes the edge weight distribution for a given target gene to determine the optimal set of TFs associated with it. Our proposed framework allows to incorporate a mechanistic active biding network based on cis-regulatory motif analysis. We evaluate our regularization framework in conjunction with two non-linear ML techniques, namely gradient boosting machines (GBM) and random-forests (GENIE), resulting in a regularized feature selection based method specifically called RGBM and RGENIE respectively. RGBM has been used to identify the main transcription factors that are causally involved as master regulators of the gene expression signature activated in the FGFR3-TACC3-positive glioblastoma. Here, we illustrate that RGBM identifies the main regulators of the molecular subtypes of brain tumors. Our analysis reveals the identity and corresponding biological activities of the master regulators characterizing the difference between G-CIMP-high and G-CIMP-low subtypes and between PA-like and LGm6-GBM, thus providing a clue to the yet undetermined nature of the transcriptional events among these subtypes.
Medical Subject Headings
Algorithms; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Glioma; Humans; Machine Learning; Microtubule-Associated Proteins; Nucleotide Motifs; Receptor, Fibroblast Growth Factor, Type 3; Transcription Factors
PubMed ID
29361062
Volume
46
Issue
7
First Page
e39
Comments
original version published by Oxford Academic, and is available at: https://doi.org/10.1093/nar/gky015, Creative Commons Attribution License